US Patent 11299551 Composite binding molecules targeting immunosuppressive B cells
Article
Provided are anti-CD19 and anti-CD38 common light chain bispecific antibodies. The anti-CD19 and anti-CD38 bispecific antibodies described herein are useful in methods for treating a cancer or a tumor.